Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mineralys Therapeutics
Mineralys Therapeutics
Biopharma’s top 5 IPOs of 2023 (so far)
Pharma Voice
Thu, 11/30/23 - 10:01 am
biotech
IPOs
Acelyrin
Apogee Therapeutics
RayzeBio
Neumora Therapeutics
Mineralys Therapeutics
7 Life Science IPOs in 2023
BioSpace
Wed, 07/12/23 - 09:48 am
IPOs
Intensity Therapeutics
Acelyrin
CytoMed Therapeutics
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
Biophama's flotation haul creeps higher
EP Vantage
Thu, 07/6/23 - 10:09 am
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
So you think you can go public? Few biotechs dance with Wall Street
Fierce Biotech
Mon, 05/8/23 - 11:52 pm
biotech
IPOs
Structure Therapeutics
Mineralys Therapeutics
Coya Therapeutics
Floating biotechs prompt tiny sparks of hope
EP Vantage
Mon, 04/10/23 - 11:16 am
IPOs
biotech
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
Mineralys reports positive data from trial of lorundrostat for hypertension
Clinical Trials Arena
Mon, 03/6/23 - 10:49 am
Mineralys Therapeutics
clinical trials
hypertension
lorundrostat
IPO Doors Creak Open as Mineralys Seeks $192M
BioSpace
Fri, 02/10/23 - 10:31 am
IPOs
Mineralys Therapeutics
hypertension
MLS-101